Novo Nordisk A/S vs Zoom Video Communications, Inc. — how do they compare? Novo Nordisk A/S trades at $49.35 (market cap $220.53B), while Zoom Video Communications, Inc. trades at $89.57 (market cap $26.66B). The key difference: Novo Nordisk A/S is far larger — about 8.3× Zoom Video Communications, Inc.'s market cap, and Novo Nordisk A/S pays a 3.63% dividend while Zoom Video Communications, Inc. pays none. Which is the better fit depends on your goals.
| NVO | ZM | |
|---|---|---|
Market Cap | $220.53B | $26.66B |
Sector | Health | Technology |
52-Week High | $71.70 | $111.88 |
52-Week Low | $35.29 | $69.77 |
Enterprise Value | $239.49B | $19.00B |
Dividend Yield | 3.63% | — |
Trailing returns across standard periods
Latest headlines on both assets
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →Zoom Video Communications, Inc. develops a people-centric cloud service that transforms real-time collaboration experience. The Company offers unified meeting experience, a cloud service that provides a 3-in-1 meeting platform with HD video conferencing, mobility, and web meetings. Zoom Video Communications serves customers worldwide.
Read more on ZM →